9-21367827-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_006900.4(IFNA13):āc.184T>Cā(p.Phe62Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000213 in 1,455,938 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006900.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IFNA13 | NM_006900.4 | c.184T>C | p.Phe62Leu | missense_variant | 1/1 | ENST00000610660.2 | NP_008831.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IFNA13 | ENST00000610660.2 | c.184T>C | p.Phe62Leu | missense_variant | 1/1 | 6 | NM_006900.4 | ENSP00000480467.1 | ||
IFNA13 | ENST00000449498.2 | c.181T>C | p.Phe61Leu | missense_variant | 1/1 | 6 | ENSP00000394494.2 |
Frequencies
GnomAD3 genomes Cov.: 25
GnomAD3 exomes AF: 0.0000335 AC: 8AN: 238756Hom.: 0 AF XY: 0.0000460 AC XY: 6AN XY: 130350
GnomAD4 exome AF: 0.0000213 AC: 31AN: 1455938Hom.: 0 Cov.: 31 AF XY: 0.0000207 AC XY: 15AN XY: 723568
GnomAD4 genome Cov.: 25
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2022 | The c.184T>C (p.F62L) alteration is located in exon 1 (coding exon 1) of the IFNA13 gene. This alteration results from a T to C substitution at nucleotide position 184, causing the phenylalanine (F) at amino acid position 62 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at